- Home
- PRTH vs PHAR Comparison
PRTH vs PHAR Comparison
Compare PRTH & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTH
- PHAR
- Stock Information
- Founded
- PRTH 2005
- PHAR 1988
- Country
- PRTH United States
- PHAR Netherlands
- Employees
- PRTH N/A
- PHAR N/A
- Industry
- PRTH EDP Services
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- PRTH Technology
- PHAR Health Care
- Exchange
- PRTH Nasdaq
- PHAR Nasdaq
- Market Cap
- PRTH 687.1M
- PHAR 587.5M
- IPO Year
- PRTH N/A
- PHAR N/A
- Fundamental
- Price
- PRTH $7.37
- PHAR $8.62
- Analyst Decision
- PRTH Strong Buy
- PHAR Strong Buy
- Analyst Count
- PRTH 4
- PHAR 3
- Target Price
- PRTH $12.75
- PHAR $30.00
- AVG Volume (30 Days)
- PRTH 672.6K
- PHAR 6.7K
- Earning Date
- PRTH 03-06-2025
- PHAR 03-13-2025
- Dividend Yield
- PRTH N/A
- PHAR N/A
- EPS Growth
- PRTH N/A
- PHAR N/A
- EPS
- PRTH N/A
- PHAR N/A
- Revenue
- PRTH $879,702,000.00
- PHAR $297,200,000.00
- Revenue This Year
- PRTH $12.42
- PHAR $8.26
- Revenue Next Year
- PRTH $11.43
- PHAR $9.73
- P/E Ratio
- PRTH N/A
- PHAR N/A
- Revenue Growth
- PRTH 16.42
- PHAR 21.15
- 52 Week Low
- PRTH $2.82
- PHAR $6.65
- 52 Week High
- PRTH $12.47
- PHAR $11.30
- Technical
- Relative Strength Index (RSI)
- PRTH 40.08
- PHAR 48.81
- Support Level
- PRTH $6.41
- PHAR $8.03
- Resistance Level
- PRTH $8.37
- PHAR $8.85
- Average True Range (ATR)
- PRTH 0.49
- PHAR 0.34
- MACD
- PRTH 0.01
- PHAR -0.01
- Stochastic Oscillator
- PRTH 49.23
- PHAR 51.73
About PRTH Priority Technology Holdings Inc.
Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium businesses enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments and Enterprise Payments. SMB Payments segment which generates majority revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging priority's proprietary software platform, distributed through ISO; B2B Payments segment provides AP automation solutions to corporations, software partners and industry FIs: and Enterprise Payments segment provides embedded payment and treasury solutions to enterprise customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.